関: phenylalanine

WordNet

the 12th letter of the Roman alphabet (同)l
an essential amino acid found in proteins and needed for growth of children and for protein metabolism in children and adults; abundant in milk and eggs; it is normally converted to tyrosine in the human body

PrepTutorEJDIC

lira(イタリアの貨幣単位リラ)
liter[s]

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/10/05 07:33:48」(JST)

wiki en

Phenylalanine /ˌfɛnᵊlˈæləˌniːn/ (abbreviated as Phe or F)^[2] is an α-amino acid with the formula C₆H₅CH₂CH(NH₂)COOH. This essential amino acid is classified as nonpolar because of the hydrophobic nature of the benzyl side chain. L-Phenylalanine (LPA) is an electrically neutral amino acid used to biochemically form proteins, coded for by DNA. The codons for L-phenylalanine are UUU and UUC. Phenylalanine is a precursor for tyrosine, the monoamine signaling molecules dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), and the skin pigment melanin.

Phenylalanine is found naturally in the breast milk of mammals. It is used in the manufacture of food and drink products and sold as a nutritional supplement for its reputed analgesic and antidepressant effects. It is a direct precursor to the neuromodulator phenethylamine, a commonly used dietary supplement.

History

The first description of phenylalanine was made in 1879, when Schulze and Barbieri identified a compound with the empirical formula, C₉H₁₁NO₂, in yellow lupine (Lupinus luteus) seedlings. In 1882, Erlenmeyer and Lipp first synthesized phenylalanine from phenylacetaldehyde, hydrogen cyanide, and ammonia.^[3]^[4]

The genetic codon for phenylalanine was first discovered by J. Heinrich Matthaei and Marshall W. Nirenberg in 1961. They showed that by using m-RNA to insert multiple uracil repeats into the genome of the bacterium E. coli, they could cause the bacterium to produce a polypeptide consisting solely of repeated phenylalanine amino acids. This discovery helped to establish the nature of the coding relationship that links information stored in genomic nucleic acid with protein expression in the living cell.

Dietary sources

Good sources of phenylalanine are eggs, chicken, liver, beef, milk, and soybeans.^[5] Other sources include spinach and leafy greens, tofu, amaranth leaves, and lupin seeds.

Other biological roles

L-Phenylalanine is biologically converted into L-tyrosine, another one of the DNA-encoded amino acids. L-tyrosine in turn is converted into L-DOPA, which is further converted into dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline). The latter three are known as the catecholamines.

Phenylalanine uses the same active transport channel as tryptophan to cross the blood–brain barrier. In excessive quantities, supplementation can interfere with the production of serotonin and other aromatic amino acids as well as nitric oxide due to the overuse (eventually, limited availability) of the associated cofactors, iron or tetrahydrobiopterin. The corresponding enzymes in for those compounds are the aromatic amino acid hydroxylase family and nitric oxide synthase.

Human biosynthesis pathway for trace amines and catecholamines^[6]^[7]

L-Phenylalanine

L-Tyrosine

L-Dopa

Epinephrine

Phenethylamine

p-Tyramine

Dopamine

Norepinephrine

N-Methylphenethylamine

N-Methyltyramine

p-Octopamine

Synephrine

3-Methoxytyramine

AADC

PNMT

AAAH

COMT

DBH

Phenylalanine in humans may ultimately be metabolized into a range of different substances.

In plants

Phenylalanine is the starting compound used in the flavonoid biosynthesis. Lignan is derived from phenylalanine and from tyrosine. Phenylalanine is converted to cinnamic acid by the enzyme phenylalanine ammonia-lyase.^[8]

Phenylketonuria

The genetic disorder phenylketonuria (PKU) is the inability to metabolize phenylalanine. Individuals with this disorder are known as "phenylketonurics" and must regulate their intake of phenylalanine. A (rare) "variant form" of phenylketonuria called hyperphenylalaninemia is caused by the inability to synthesize a cofactor called tetrahydrobiopterin, which can be supplemented. Pregnant women with hyperphenylalaninemia may show similar symptoms of the disorder (high levels of phenylalanine in blood) but these indicators will usually disappear at the end of gestation. Individuals who cannot metabolize phenylalanine must monitor their intake of protein to control the buildup of phenylalanine as their bodies convert protein into its component amino acids.

Phenylketonurics often use blood tests to monitor the amount of phenylalanine in their blood. Lab results may report phenylalanine levels in different units, including mg/dL and μmol/L. One mg/dL of phenylalanine is approximately equivalent to 60 μmol/L.

A non-food source of phenylalanine is the artificial sweetener aspartame. This compound, sold under the trade names Equal and NutraSweet, is metabolized by the body into several chemical byproducts including phenylalanine. The breakdown problems phenylketonurics have with protein and the attendant buildup of phenylalanine in the body also occurs with the ingestion of aspartame, although to a lesser degree. Accordingly, all products in Australia, the U.S. and Canada that contain aspartame must be labeled: "Phenylketonurics: Contains phenylalanine." In the UK, foods containing aspartame must carry ingredient panels that refer to the presence of "aspartame or E951"^[9] and they must be labeled with a warning "Contains a source of phenylalanine." In Brazil, the label "Contém Fenilalanina" (Portuguese for "Contains Phenylalanine") is also mandatory in products which contain it. These warnings are placed to aid individuals who have been diagnosed with PKU so that they can avoid such foods.

Geneticists have recently sequenced the genome of macaques. Their investigations have found "some instances where the normal form of the macaque protein looks like the diseased human protein" including markers for PKU.^[10]

D-, L- and DL-phenylalanine

The stereoisomer D-phenylalanine (DPA) can be produced by conventional organic synthesis, either as a single enantiomer or as a component of the racemic mixture. It does not participate in protein biosynthesis although it is found in proteins in small amounts - particularly aged proteins and food proteins that have been processed. The biological functions of D-amino acids remain unclear, although D-phenylalanine has pharmacological activity at niacin receptor 2.^[11]

DL-Phenylalanine (DLPA) is marketed as a nutritional supplement for its supposed analgesic and antidepressant activities. DL-Phenylalanine is a mixture of D-phenylalanine and L-phenylalanine. The reputed analgesic activity of DL-phenylalanine may be explained by the possible blockage by D-phenylalanine of enkephalin degradation by the enzyme carboxypeptidase A.^[12] The mechanism of DL-phenylalanine's supposed antidepressant activity may be accounted for by the precursor role of L-phenylalanine in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain levels of norepinephrine and dopamine are thought to have an antidepressant effect. D-Phenylalanine is absorbed from the small intestine and transported to the liver via the portal circulation. A small amount of D-phenylalanine appears to be converted to L-phenylalanine. D-Phenylalanine is distributed to the various tissues of the body via the systemic circulation. It appears to cross the blood–brain barrier less efficiently than L-phenylalanine, and so a small amount of an ingested dose of D-phenylalanine is excreted in the urine without penetrating the central nervous system.^{[citation needed]}

L-Phenylalanine is an antagonist at α2δ Ca²⁺ calcium channels with a K_i of 980 nM.^[13] At higher doses, this may play a role in its analgesic and antidepressant properties.

In the brain, L-phenylalanine is a competitive antagonist at the glycine binding site of NMDA receptor^[14] and at the glutamate binding site of AMPA receptor.^[15] At the glycine binding site of NMDA receptor L-phenylalanine has an apparent equilibrium dissociation constant (K_B) of 573 µM estimated by Schild regression^[16] which is considerably lower than brain L-phenylalanine concentration observed in untreated human phenylketonuria.^[17] L-Phenylalanine also inhibits neurotransmitter release at glutamatergic synapses in hippocampus and cortex with IC₅₀ of 980 µM, a brain concentration seen in classical phenylketonuria, whereas D-phenylalanine has a significantly smaller effect.^[15]

Commercial synthesis

L-Phenylalanine is produced for medical, feed, and nutritional applications, such as aspartame, in large quantities by utilizing the bacterium Escherichia coli, which naturally produces aromatic amino acids like phenylalanine. The quantity of L-phenylalanine produced commercially has been increased by genetically engineering E. coli, such as by altering the regulatory promoters or amplifying the number of genes controlling enzymes responsible for the synthesis of the amino acid.^[18]

References

^ Dawson, R. M. C.; et al. (1959). Data for Biochemical Research. Oxford: Clarendon Press.
^ IUPAC-IUBMB Joint Commission on Biochemical Nomenclature (1983). "Nomenclature and Symbolism for Amino Acids and Peptides". Recommendations on Organic & Biochemical Nomenclature, Symbols & Terminology etc. Retrieved 2007-05-17.
^ Thorpe, T. E. (1913). A Dictionary of Applied Chemistry. Longmans, Green, and Co. pp. 191–193. Retrieved 2012-06-04.
^ Plimmer, R. H. A. (1912) [1908]. Plimmer, R. H. A.; Hopkins, F. G., ed. The Chemical Composition of the Proteins. Monographs on Biochemistry. Part I. Analysis (2nd ed.). London: Longmans, Green and Co. pp. 93–97. Retrieved 2012-06-04.
^ Harvey M. Ross; June Roth (1 April 1991). The Mood Control Diet: 21 Days to Conquering Depression and Fatigue. Simon & Schuster. p. 59. ISBN 978-0-13-590449-7.
^ Broadley KJ (March 2010). "The vascular effects of trace amines and amphetamines". Pharmacol. Ther. 125 (3): 363–375. doi:10.1016/j.pharmthera.2009.11.005. PMID 19948186.
^ Lindemann L, Hoener MC (May 2005). "A renaissance in trace amines inspired by a novel GPCR family". Trends Pharmacol. Sci. 26 (5): 274–281. doi:10.1016/j.tips.2005.03.007. PMID 15860375.
^ Nelson, D. L.; Cox, M. M. (2000). Lehninger, Principles of Biochemistry (3rd ed.). New York: Worth Publishing. ISBN 1-57259-153-6.
^ "Aspartame". UK: Food Standards Agency.
^ Gibbs, R. A.; et al. (2007). "Evolutionary and Biomedical Insights from the Rhesus Macaque Genome" (pdf). Science 316 (5822): 222–234. doi:10.1126/science.1139247. PMID 17431167.
^ "D-phenylalanine". IUPHAR. Retrieved 24 June 2014.
^ Christianson, D. W.; Mangani, S.; Shoham, G.; Lipscomb, W. N. (1989). "Binding of D-Phenylalanine and D-Tyrosine to Carboxypeptidase A" (pdf). Journal of Biological Chemistry 264 (22): 12849–12853. PMID 2568989.
^ Mortell KH, Anderson DJ, Lynch JJ, et al. (March 2006). "Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels". Bioorganic & Medicinal Chemistry Letters 16 (5): 1138–41. doi:10.1016/j.bmcl.2005.11.108. PMID 16380257.
^ Glushakov, AV; Dennis, DM; Morey, TE; Sumners, C; Cucchiara, RF; Seubert, CN; Martynyuk, AE (2002). "Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria.". Molecular psychiatry 7 (4): 359–67. doi:10.1038/sj.mp.4000976. PMID 11986979.
^ ^a ^b Glushakov, AV; Dennis, DM; Sumners, C; Seubert, CN; Martynyuk, AE (Apr 1, 2003). "L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses.". Journal of neuroscience research 72 (1): 116–24. doi:10.1002/jnr.10569. PMID 12645085.
^ Glushakov, AV; Glushakova, O; Varshney, M; Bajpai, LK; Sumners, C; Laipis, PJ; Embury, JE; Baker, SP; Otero, DH; Dennis, DM; Seubert, CN; Martynyuk, AE (February 2005). "Long-term changes in glutamatergic synaptic transmission in phenylketonuria.". Brain : a journal of neurology 128 (Pt 2): 300–7. doi:10.1093/brain/awh354. PMID 15634735.
^ Möller, HE; Weglage, J; Bick, U; Wiedermann, D; Feldmann, R; Ullrich, K (December 2003). "Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.". Pediatrics 112 (6 Pt 2): 1580–3. PMID 14654669.
^ Sprenger, G. A. (2007). "Aromatic Amino Acids". Amino Acid Biosynthesis: Pathways, Regulation and Metabolic Engineering (1st ed.). Springer. pp. 106–113. ISBN 978-3-540-48595-7.

External links

Phenylalanine mass spectrum
Phenylalanine at ChemSynthesis
Food Sources of Phenylalanine

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. フェニルケトン尿症の概要 overview of phenylketonuria
2. アスリートにおけるオーバートレーニング症候群 overtraining syndrome in athletes
3. チロシン代謝障害 disorders of tyrosine metabolism
4. 肝性脳症：病因 hepatic encephalopathy pathogenesis
5. ガラクトース血症：臨床的特徴および診断 galactosemia clinical features and diagnosis

English Journal

Nutrient composition and antioxidant activity of gonads of sea urchin Stomopneustes variolaris.

Archana A1, Babu KR2.
Food chemistry.Food Chem.2016 Apr 15;197(Pt A):597-602. doi: 10.1016/j.foodchem.2015.11.003. Epub 2015 Nov 2.
The study investigated, for the first time, proximate nutritional composition and antioxidant activity of gonads from the sea urchin, Stomopneustes variolaris, inhabiting the coastal area of Visakhapatnam (India). Moisture, ash, proteins, lipids and carbohydrate content were 77.53%±0.80, 3.76%±0.2
PMID 26616993

Quantitative determination of carboxylic acids, amino acids, carbohydrates, ethanol and hydroxymethylfurfural in honey by (1)H NMR.

Del Campo G1, Zuriarrain J1, Zuriarrain A1, Berregi I2.
Food chemistry.Food Chem.2016 Apr 1;196:1031-9. doi: 10.1016/j.foodchem.2015.10.036. Epub 2015 Oct 22.
A method using (1)H NMR spectroscopy has been developed to quantify simultaneously thirteen analytes in honeys without previous separation or pre-concentration steps. The method has been successfully applied to determine carboxylic acids (acetic, formic, lactic, malic and succinic acids), amino acid
PMID 26593586

Antagonism between lipid-derived reactive carbonyls and phenolic compounds in the Strecker degradation of amino acids.

Delgado RM1, Hidalgo FJ1, Zamora R2.
Food chemistry.Food Chem.2016 Mar 1;194:1143-8. doi: 10.1016/j.foodchem.2015.07.126. Epub 2015 Aug 5.
The Strecker-type degradation of phenylalanine in the presence of 2-pentanal and phenolic compounds was studied to investigate possible interactions that either promote or inhibit the formation of Strecker aldehydes in food products. Phenylacetaldehyde formation was promoted by 2-pentenal and also b
PMID 26471665

Japanese Journal

Widely targeted metabolic profiling analysis of yeast central metabolites(METHODS)

Kato Hiroko,Izumi Yoshihiro,Hasunuma Tomohisa,Matsuda Fumio,Kondo Akihiko
Journal of bioscience and bioengineering 113(5), 665-673, 2012-05
… For example, limits of detection for lactate and L-phenylalanine were 1.4 fmol and 2.0 fmol, respectively. …
NAID 110009456911

N-acetyl-3,4-dihydroxy-L-phenylalanine, a second identified bioactive metabolite produced by Streptomyces sp. 8812

SOLECKA Jolanta,RAJNISZ Aleksandra,POSTEK Magdalena,ZAJKO Joanna,KAWECKI Robert,HAVLICEK Vladimir,BEDNAREK Elzbieta,KOZERSKI Lech
Journal of antibiotics 65(4), 219-221, 2012-04-25
NAID 10030641414

Evaluation of the In Vivo Antioxidant Activity of Mucuna pruriens DC. var. utilis by Using Caenorhabditis elegans

IBE Sachie,FUJII Yoshiharu,OTOBE Kazunori
Food Science and Technology Research 18(2), 227-233, 2012
… Mucuna pruriens (MP) is a legume with seeds that contain substantial amounts of 3, 4-dihydroxy-L-phenylalanine (L-DOPA; … L-DOPA showed high 1,1-diphenyl-2-picrylhydrazyl (DPPH)-radical scavenging activity but did not contribute to the antioxidant activity of MP in vivo. …
NAID 130001922851

「L-フェニルアラニン」

Phenylalanine
	; L-Phenylalanine
	; L-Phenylalanine
Names
	IUPAC name Phenylalanine
	Other names 2-Amino-3-phenylpropanoic acid
Identifiers
CAS Registry Number	150-30-1 (DL) ; 63-91-2 (L)
ChEBI	CHEBI:58095
ChEMBL	ChEMBL301523
ChemSpider	5910
DrugBank	DB00120
	InChI InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1 ; Key: COLNVLDHVKWLRT-QMMMGPOBSA-N ; InChI=1/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1; Key: COLNVLDHVKWLRT-QMMMGPOBBC ;
IUPHAR/BPS	3313
KEGG	D00021
PubChem	994
UNII	8P946UF12S
Properties
Chemical formula	C9H11NO2
Molar mass	165.19 g·mol−1
Acidity (pKa)	1.83 (carboxyl), 9.13 (amino)
Hazards
Safety data sheet	See: data page
NFPA 704	1 2 0
Supplementary data page
Structure and; properties	Refractive index (n),; Dielectric constant (εr), etc.
Thermodynamic; data	Phase behaviour; solid–liquid–gas
Spectral data	UV, IR, NMR, MS
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is: /?)
	Infobox references

　　[★]

英: L-phenylalanine
関: フェニルアラニン

「L-aspartyl-L-phenylalanine methyl ester」

　　[★] アスパルチルフェニルアラニンメチルエステル

「L」

　　[★]

「phenylalanine」

　　[★] フェニルアラニン

[1] Dawson, R. M. C.; et al. (1959). Data for Biochemical Research. Oxford: Clarendon Press.

[2] IUPAC-IUBMB Joint Commission on Biochemical Nomenclature (1983). "Nomenclature and Symbolism for Amino Acids and Peptides". Recommendations on Organic & Biochemical Nomenclature, Symbols & Terminology etc. Retrieved 2007-05-17.

[3] Thorpe, T. E. (1913). A Dictionary of Applied Chemistry. Longmans, Green, and Co. pp. 191–193. Retrieved 2012-06-04.

[4] Plimmer, R. H. A. (1912) [1908]. Plimmer, R. H. A.; Hopkins, F. G., ed. The Chemical Composition of the Proteins. Monographs on Biochemistry. Part I. Analysis (2nd ed.). London: Longmans, Green and Co. pp. 93–97. Retrieved 2012-06-04.

[RossRoth1991-5] Harvey M. Ross; June Roth (1 April 1991). The Mood Control Diet: 21 Days to Conquering Depression and Fatigue. Simon & Schuster. p. 59. ISBN 978-0-13-590449-7.

[Trace_amine_template_1-6] Broadley KJ (March 2010). "The vascular effects of trace amines and amphetamines". Pharmacol. Ther. 125 (3): 363–375. doi:10.1016/j.pharmthera.2009.11.005. PMID 19948186.

[Trace_amine_template_2-7] Lindemann L, Hoener MC (May 2005). "A renaissance in trace amines inspired by a novel GPCR family". Trends Pharmacol. Sci. 26 (5): 274–281. doi:10.1016/j.tips.2005.03.007. PMID 15860375.

[Nelson-8] Nelson, D. L.; Cox, M. M. (2000). Lehninger, Principles of Biochemistry (3rd ed.). New York: Worth Publishing. ISBN 1-57259-153-6.

[9] "Aspartame". UK: Food Standards Agency.

[10] Gibbs, R. A.; et al. (2007). "Evolutionary and Biomedical Insights from the Rhesus Macaque Genome" (pdf). Science 316 (5822): 222–234. doi:10.1126/science.1139247. PMID 17431167.

[11] "D-phenylalanine". IUPHAR. Retrieved 24 June 2014.

[12] Christianson, D. W.; Mangani, S.; Shoham, G.; Lipscomb, W. N. (1989). "Binding of D-Phenylalanine and D-Tyrosine to Carboxypeptidase A" (pdf). Journal of Biological Chemistry 264 (22): 12849–12853. PMID 2568989.

[pmid16380257-13] Mortell KH, Anderson DJ, Lynch JJ, et al. (March 2006). "Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels". Bioorganic & Medicinal Chemistry Letters 16 (5): 1138–41. doi:10.1016/j.bmcl.2005.11.108. PMID 16380257.

[14] Glushakov, AV; Dennis, DM; Morey, TE; Sumners, C; Cucchiara, RF; Seubert, CN; Martynyuk, AE (2002). "Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria.". Molecular psychiatry 7 (4): 359–67. doi:10.1038/sj.mp.4000976. PMID 11986979.

[Glushakov_116.E2.80.9324-15] Glushakov, AV; Dennis, DM; Sumners, C; Seubert, CN; Martynyuk, AE (Apr 1, 2003). "L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses.". Journal of neuroscience research 72 (1): 116–24. doi:10.1002/jnr.10569. PMID 12645085.

[16] Glushakov, AV; Glushakova, O; Varshney, M; Bajpai, LK; Sumners, C; Laipis, PJ; Embury, JE; Baker, SP; Otero, DH; Dennis, DM; Seubert, CN; Martynyuk, AE (February 2005). "Long-term changes in glutamatergic synaptic transmission in phenylketonuria.". Brain : a journal of neurology 128 (Pt 2): 300–7. doi:10.1093/brain/awh354. PMID 15634735.

[17] Möller, HE; Weglage, J; Bick, U; Wiedermann, D; Feldmann, R; Ullrich, K (December 2003). "Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.". Pediatrics 112 (6 Pt 2): 1580–3. PMID 14654669.

[18] Sprenger, G. A. (2007). "Aromatic Amino Acids". Amino Acid Biosynthesis: Pathways, Regulation and Metabolic Engineering (1st ed.). Springer. pp. 106–113. ISBN 978-3-540-48595-7.

リンク元	「L-フェニルアラニン」
拡張検索	「L-aspartyl-L-phenylalanine methyl ester」
関連記事	「L」「phenylalanine」

匿名

検索

案内

案内

L-phenylalanine